Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-Vmp) Versus Bortezomib, Melphalan, and Prednisone (Vmp) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (Ndmm): Updated Analysis of the Phase 3 Alcyone Study

AuthID
 P-00Y-1RF
25
Author(s)
Mateos, MV
·
Suzuki, K
·
Jakubowiak, A
·
Knop, S
·
Lucio, P
·
Nagy, Z
·
[+5]·
Shelekhova, T
·
Yoon, SS
·
Iosava, G
·
Fujisaki, T
·
Garg, M
·
Pei, HL
·
Krevvata, M
·
Carson, R
·
Borgsten, F
·
Dimopoulos, MA
View all authors
Tipo de Documento
Abstract
Year published
2022
Publicado
in BLOOD, ISSN: 0006-4971
Volume: 140, Páginas: 10157-10159 (3)
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:000893230303073
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.
All authors
Name Order Nome   Name Order Nome   Name Order Nome
1 Mateos, MV;   2 San-Miguel, J;   3 Cavo, M;
4 Creixenti, JB;   5 Suzuki, K;   6 Jakubowiak, A;
7 Knop, S;   8 Doyen, C;   9 Lucio, P;
10 Nagy, Z;   11 Pour, L;   12 Grosicki, S;
13 Crepaldi, AH;   14 Liberati, AM;   15 Campbell, P;
16 Shelekhova, T;   17 Yoon, SS;   18 Iosava, G;
19 Fujisaki, T;   20 Garg, M;   21 Pei, HL;
22 Krevvata, M;   23 Carson, R;   24 Borgsten, F;
25 Dimopoulos, MA;    

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service